69 results on '"Klocker, Helmut"'
Search Results
2. Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer
3. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions
4. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance
5. Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells
6. Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer
7. Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites
8. Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells
9. Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?
10. ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells
11. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia
12. Quantitative measurement of the androgen receptor in prepuces of boys with and without hypospadias
13. Anterior gradient 2and3- two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells
14. Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target?
15. In memoriam of Georg Bartsch, MD, Professor of urology (1942-2012)
16. Serum‐autoantibodies for discovery of prostate cancer specific biomarkers
17. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection
18. Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy
19. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A
20. Insulin‐like growth factor binding protein‐3 (IGFBP‐3) in the prostate and in prostate cancer: Local production, distribution and secretion pattern indicate a role in stromal‐epithelial interaction
21. Insulin‐Like Growth Factor‐Binding Protein‐5 Enters Vesicular Structures but Not the Nucleus
22. Influence of blood sampling on protein profiling and pattern analysis using matrix-assisted laser desorption/ionisation mass spectrometry
23. Development of a cell-isolation method for human prostatic smooth muscle cells based on cell type-specific activation of the SM22 gene promoter
24. Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: Cancer association of annexin A3
25. Estrogens and aspects of prostate disease
26. Longitudinal PSA changes in men with and without prostate cancer: Assessment of prostate cancer risk
27. Small G‐protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis
28. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: Association with progression and angiogenesis
29. Ability of PSA-positive circulating macrophages to detect prostate cancer
30. Long‐term androgen‐ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells
31. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population
32. Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells
33. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia
34. Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens
35. Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity
36. Human rhabdosphincter cell culture: A model for videomicroscopy of cell contractions
37. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue
38. Expression and function of androgen receptor in carcinoma of the prostate
39. Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models
40. Effects of ?1-adrenoceptor antagonists on cultured prostatic smooth muscle cells
41. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an ?1-adrenergic receptor antagonist
42. Videoimaging of prostatic stromal-cell contraction: An in vitro model for studying drug effects
43. Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinoma
44. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
45. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line
46. Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells
47. Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors
48. Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate
49. Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers
50. Frequency and clinical significance of transition zone cancer in prostate cancer screening
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.